. 2020 Jun 5;16(13):2296–2305. doi: 10.7150/ijbs.45457

Table 1.

Correlation between LINC01123 expression and clinicopathologic characteristics in hepatocellular carcinoma

Characteristics		n=80	LINC01123		P (chi-square test)
Characteristics		n=80	Low expression (n=40)	High expression (n=40)	P (chi-square test)
Age (years)	<50	35	17	18	0.822
Age (years)	≥50	45	23	22	0.822
Sex	Male	63	34	29	0.172
Sex	Female	17	6	11	0.172
HBV	No	28	16	12	0.348
HBV	Yes	52	24	28	0.348
Serum AFP level (ng/mL)	<20	27	15	12	0.478
Serum AFP level (ng/mL)	≥20	53	25	28	0.478
Tumor size (cm)	<5	26	19	7	0.004^*
Tumor size (cm)	≥5	54	21	33	0.004^*
No. of tumor nodules	1	65	35	30	0.152
No. of tumor nodules	≥2	15	5	10	0.152
Cirrhosis	No	35	19	16	0.499
Cirrhosis	Yes	45	21	24	0.499
Venous infiltration	No	44	27	17	0.025^*
Venous infiltration	Yes	36	13	23	0.025^*
Edmondson-Steiner grade	I+II	57	32	25	0.084
Edmondson-Steiner grade	III+IV	23	8	15	0.084
TNM stage	I+II	63	37	26	0.003^*
TNM stage	III+IV	17	3	14	0.003^*

HBV, hepatitis B virus; AFP, alpha-fetoprotein; TNM, tumor-node-metastasis.

The “low” or “high” expression of LINC01123 level was defined according to the cut-off value, which was defined as the median value of the cohort of patients tested. *Statistically significant.